Repurposing of cholesterol-lowering agents in status epilepticus: A neuroprotective effect of simvastatin
Epilepsy & Behavior · 2023
DOI: 10.1016/j.yebeh.2023.109133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Aurélie Hanin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, 47 Boulevard de l'Hôpita…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Status Epilepticus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: ANR, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
The increase of cholesterol synthesis after a status epilepticus may lead to excitotoxic processes, neuronal loss and favor the appearance of spontaneous epileptic seizures. Lowering cholesterol content could be a neuroprotective strategy. Here, we evaluated the protective effect of simvastatin administrated daily for 14 days, after the induction of a status epilepticus by intrahippocampal injection of kainic acid in mice. The results were compared to those obtained from mice showing a kainic acid-induced status epilepticus, treated daily with a saline solution, and from mice injected with a control phosphate-buffered solution without any status epilepticus. We first assessed the antiseizure effects of simvastatin by performing video-electroencephalographic recordings during the first three hours after kainic acid injection and continuously between the fifteenth and the thirty-first days. Mice treated with simvastatin had significantly fewer generalized seizures during the first three hours without a significant effect on generalized seizures after two weeks. There was a trend for fewer hippocampal electrographic seizures after two weeks. Secondly, we evaluated the neuroprotective and anti-inflammatory effects of simvastatin by measuring the fluorescence of neuronal and astrocyte markers on the thirtieth day after status onset. We found that simvastatin reduced CA1 reactive astrocytosis, demonstrated by a significant 37% decrease in GFAP-positive cells, and that simvastatin prevented the neuronal loss in CA1, demonstrated by a significant 42% increase in the NeuN-positive cells, as compared to the findings in mice with kainic acid-induced status epilepticus treated by a saline solution. Our study confirms the interest of cholesterol-lowering agents, and in particular simvastatin, in status epilepticus and paves the way for a clinical pilot study to prevent neurological sequelae after status epilepticus. This paper was presented at the 8th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures held in September 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France; AP-HP, Hôpital de la Pitié-Salpêtrière, DMU Ne…
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France.
Förderung
- ANR
- Fondation pour la Recherche Médicale
Zitieren
APA
Hanin, A., Roussel, D., Lecas, S., Baudin, P., & Navarro, V. (2023). Repurposing of cholesterol-lowering agents in status epilepticus: A neuroprotective effect of simvastatin. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109133
Vancouver
Hanin A, Roussel D, Lecas S, Baudin P, Navarro V. Repurposing of cholesterol-lowering agents in status epilepticus: A neuroprotective effect of simvastatin. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109133
BibTeX
@article{Hanin2023,
author = {Hanin, Aurélie and Roussel, Delphine and Lecas, Sarah and Baudin, Paul and Navarro, Vincent},
title = {Repurposing of cholesterol-lowering agents in status epilepticus: A neuroprotective effect of simvastatin},
journal = {Epilepsy & Behavior},
year = {2023},
doi = {10.1016/j.yebeh.2023.109133}
}
EUVIMED